Free Trial

Lexeo Therapeutics (LXEO) SEC Filings & 10K Form

Lexeo Therapeutics logo
$4.80 +0.01 (+0.10%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Lexeo Therapeutics SEC Filings

DateFilerForm TypeView
08/27/2025
5:51 PM
Lexeo Therapeutics (Issuer)
Tamayo Louis Edward (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/20/2025
3:58 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
4:00 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
4:02 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
4:03 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
4:05 PM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
2:18 PM
Lexeo Therapeutics (Subject)
Robertson Jenny (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2025
2:20 PM
Lexeo Therapeutics (Subject)
See Tai Sandi (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2025
2:24 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2025
2:26 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2025
2:31 PM
Lexeo Therapeutics (Subject)
Otero Jose Manuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2025
10:46 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
08/14/2025
6:31 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025
6:33 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2025
5:40 AM
BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G
07/01/2025
7:09 AM
Lexeo Therapeutics (Filer)
Form 424B3
06/30/2025
11:15 PM
Lexeo Therapeutics (Filer)
Form EFFECT
06/30/2025
3:47 PM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
3:56 PM
Lexeo Therapeutics (Filer)
Form S-3/A
06/05/2025
3:52 PM
Lexeo Therapeutics (Filer)
Form DEFA14A
06/04/2025
3:51 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G
06/04/2025
3:04 PM
Affinity Asset Advisors, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G
05/27/2025
6:32 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
2:35 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:36 PM
Lexeo Therapeutics (Subject)
See Tai Sandi (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:41 PM
Lexeo Therapeutics (Subject)
Robertson Jenny (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:51 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
8:58 AM
D1 Capital Partners L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
11:00 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
05/13/2025
5:55 AM
Lexeo Therapeutics (Subject)
MIZUHO FINANCIAL GROUP INC (Filed by)
Form SCHEDULE 13G/A
05/12/2025
8:00 AM
Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
05/12/2025
6:02 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
6:03 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/09/2025
4:44 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
4:46 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
4:48 PM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
5:06 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
6:58 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:17 PM
Lexeo Therapeutics (Filer)
Form S-8 POS
03/24/2025
6:52 AM
Lexeo Therapeutics (Filer)
Form 424B5
03/24/2025
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s Plan May Undo 1933’s Biggest Financial Injustice (Ad)

Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.tc pixel

Claim Your FREE Guide Now and discover how to position yourself for this golden opportunity.
03/24/2025
6:03 AM
Lexeo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2025
6:04 AM
Lexeo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/21/2025
4:08 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:09 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:09 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:10 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:06 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
11:03 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:55 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM
Lexeo Therapeutics (Subject)
Omega Fund VI, L.P. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
9:24 AM
Lexeo Therapeutics (Subject)
MIZUHO FINANCIAL GROUP INC (Filed by)
Form SCHEDULE 13G
02/12/2025
8:35 AM
Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SCHEDULE 13G/A
01/22/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Rasbach Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:35 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:55 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
3:55 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
1:59 PM
Lexeo Therapeutics (Issuer)
Rasbach Kyle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2024
11:15 PM
Lexeo Therapeutics (Filer)
Form EFFECT
12/19/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
7:19 AM
Lexeo Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/12/2024
4:00 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:18 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
11:15 PM
Lexeo Therapeutics (Filer)
Form EFFECT
11/26/2024
4:00 PM
CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:49 PM
Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
Form SC 13G/A
11/14/2024
11:32 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
11/14/2024
11:23 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:31 PM
Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:33 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:34 PM
Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:31 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:32 AM
Lexeo Therapeutics (Filer)
Form 424B3
11/13/2024
6:33 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:35 AM
Lexeo Therapeutics (Filer)
Form 424B3
11/12/2024
8:31 AM
Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G
10/30/2024
5:15 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
5:17 AM
Lexeo Therapeutics (Filer)
Form 424B3
10/15/2024
12:45 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:30 PM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:32 PM
Lexeo Therapeutics (Filer)
Form 424B3
09/11/2024
4:17 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:39 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LXEO) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners